Summary
PHARMASENSE is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.3m and a net result of €157,945. Equity is growing by ~9.1% per year across the filed fiscal years. Its solvency ranks better than 62% of 8211 sector peers (fiscal year 2025). The company has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
What they do
Activities of holding companies
NACE 64210Holdings NACE 64200
1 site
How big
€1.9mtotal assets 2025
- Equity
- €1.3m
- Profit
- €157,945
Turnover not published (abridged schema)
Financially healthy?
Financial institution: outside the modelProbability: sector outside the model
Who decides
- Holdings
- 1
Accounts filed 28 d late0 of 3 deeds read
SignalsFiled after the deadlineShow the evidence
Checked score
Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
28 d late
2024
26 d late
2023
21 d late
2022
31 d late
2021
39 d early
2020
31 d late
2019
46 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 7 days after the deadline; the sector median for financial year 2024 is 14 days before the deadline, and 28% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 26 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · micro…
- Highest result since 2018net €157,945 ▲6%
- Annual accounts filedfiscal year 2024 · micro…
Financials
Fiscal year 2025Total assets €1.9mProfit €157,945Solvency 65.1%Liquidity 0.17
Total assets
€1.9m▼ 0.3%
2018 - 2025
Net result
€157,945▲ 6.0%
2018 - 2025
Equity
€1.3m▲ 14.4%
2018 - 2025
Solvency
65.1%▲ 8.3pp
2018 - 2025
Financials · fiscal year 2025, micro schema
Trend over the years
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 64, Financial service activities, except insurance and pension funding, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€0.2m▲ 27.4%€0.2m▲ 17.2%€0.2m▲ 7.5%€0.2m▼ 1.1%€0.2m▲ 2.8%
Net result€0.1mabove the sector's middle half▲ 25.6%€0.2mabove the sector's middle half▲ 23.2%€0.1mabove the sector's middle half▼ 14.0%€0.1mabove the sector's middle half▲ 10.6%€0.2mabove the sector's middle half▲ 6.0%
Equity€1.0mabove the sector's middle half▲ 15.4%€1.0mabove the sector's middle half▲ 2.8%€1.1mabove the sector's middle half▲ 13.7%€1.1mabove the sector's middle half▼ 1.6%€1.3mabove the sector's middle half▲ 14.4%
Total assets€1.9mabove the sector's middle half▲ 32.2%€2.0mabove the sector's middle half▲ 1.7%€2.2mabove the sector's middle half▲ 12.5%€1.9mabove the sector's middle half▼ 12.9%€1.9mabove the sector's middle half▼ 0.3%
Debt€1.0m▲ 53.9%€1.0m▲ 0.6%€1.1m▲ 11.3%€0.8m▼ 24.2%€0.7m▼ 19.5%
Working capital-€0.6mbelow the sector's middle half▼ 189%-€0.7mbelow the sector's middle half▼ 11.1%-€0.3mbelow the sector's middle half▲ 58.5%-€0.4mbelow the sector's middle half▼ 47.7%-€0.3mbelow the sector's middle half▲ 23.2%
Solvency49.1%within the sector's middle half▼ 7.2pp49.7%within the sector's middle half▲ 0.5pp50.2%within the sector's middle half▲ 0.5pp56.7%within the sector's middle half▲ 6.5pp65.1%within the sector's middle half▲ 8.3pp
Current ratio0.13below the sector's middle half▼ 0.080.16below the sector's middle half▲ 0.020.57below the sector's middle half▲ 0.410.17below the sector's middle half▼ 0.400.17below the sector's middle half=
Return on assets (ROA)6.5%within the sector's middle half▼ 0.3pp7.9%within the sector's middle half▲ 1.4pp6.1%within the sector's middle half▼ 1.9pp7.7%within the sector's middle half▲ 1.6pp8.2%within the sector's middle half▲ 0.5pp
above
within
below
the middle half (P25 to P75) of NACE 64, Financial service activities, except insurance and pension funding, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result and balance sheet
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 3% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.9m
Fixed assets
€1.9m ▲ 0.9%
Current assets
€64,465 ▼ 25.8%
Equity and liabilities €1.9m
Equity
€1.3m ▲ 14.4%
Debt
€674,451 ▼ 19.5%
Debt's share of the balance-sheet total falls from 43.3% to 34.9%. Equity is higher and debt is lower.
Key figures and ratios
Key figures and ratios
ROE
12.6%▼
2024 · 13.6%
Debt ≤ 1 year
€386,543▼
2024 · €506,002
Debt > 1 year
€284,458▼
2024 · €325,128
Income taxes
€67,999▲
2024 · €65,000
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | - | - | - | €1,737 | - |
| Other operating charges640/8 | €969 | €970 | €1,069 | €118 | €1,099 | ▲ 832% |
| Gross operating margin9900 | €189,161 | €221,504 | €238,092 | €234,437 | €243,670 | ▲ 3.9% |
| Operating profit (loss)9901 | €188,192 | €220,534 | €237,023 | €234,319 | €240,835 | ▲ 2.8% |
| Financial income75/76B | - | - | €414 | - | - | - |
| Recurring financial income75 | - | - | €414 | - | - | - |
| Financial charges65/66B | €15,556 | €12,387 | €22,280 | €20,312 | €14,890 | ▼ 26.7% |
| Recurring financial charges65 | €15,556 | €12,387 | €22,280 | €20,312 | €14,890 | ▼ 26.7% |
| Profit (loss) for the period before taxes9903 | €172,635 | €208,147 | €215,157 | €214,006 | €225,944 | ▲ 5.6% |
| Income taxes67/77 | €45,577 | €51,609 | €80,474 | €65,000 | €67,999 | ▲ 4.6% |
| Profit (loss) for the period9904 | €127,058 | €156,539 | €134,683 | €149,006 | €157,945 | ▲ 6.0% |
| Profit (loss) for the period to be appropriated9905 | €127,058 | €156,539 | €134,683 | €149,006 | €157,945 | ▲ 6.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.9m | €2.0m | €2.2m | €1.9m | €1.9m | ▼ 0.3% |
| Fixed assets21/28 | €1.8m | €1.8m | €1.8m | €1.8m | €1.9m | ▲ 0.9% |
| Tangible fixed assets22/27 | - | - | - | - | €0.02m | - |
| Other tangible fixed assets26 | - | - | - | - | €0.02m | - |
| Financial fixed assets28 | €1.8m | €1.8m | €1.8m | €1.8m | €1.8m | = |
| Current assets29/58 | €0.09m | €0.1m | €0.4m | €0.09m | €0.06m | ▼ 25.8% |
| Amounts receivable within one year40/41 | €0.002m | €0.04m | €0.1m | €0.02m | €0.06m | ▲ 250% |
| Trade receivables40 | - | €0.03m | €0.03m | - | €0.05m | - |
| Other amounts receivable41 | €0.002m | €0.006m | €0.09m | €0.02m | €0.02m | ▼ 7.7% |
| Cash at bank and in hand54/58 | €0.04m | €0.09m | €0.3m | €0.07m | €5 | ▼ 100.0% |
| Deferred charges and accrued income490/1 | €0.05m | - | €71 | - | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.9m | €2.0m | €2.2m | €1.9m | €1.9m | ▼ 0.3% |
| Equity10/15 | €1.0m | €1.0m | €1.1m | €1.1m | €1.3m | ▲ 14.4% |
| Contributions10/11 | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | = |
| Reserves13 | €0.9m | €1.0m | €1.1m | €1.1m | €1.2m | ▲ 14.6% |
| Non-distributable reserves130/1 | €0.002m | €0.002m | - | - | - | - |
| Reserves not available under the articles1311 | €0.002m | €0.002m | - | - | - | - |
| Distributable reserves133 | €0.9m | €1.0m | €1.1m | €1.1m | €1.2m | ▲ 14.6% |
| Amounts payable17/49 | €1.0m | €1.0m | €1.1m | €0.8m | €0.7m | ▼ 19.5% |
| Amounts payable after more than one year17 | €0.3m | €0.2m | €0.4m | €0.3m | €0.3m | ▼ 12.5% |
| Financial debts170/4 | €0.3m | €0.2m | €0.4m | €0.3m | €0.3m | ▼ 12.5% |
| Amounts payable within one year42/48 | €0.7m | €0.8m | €0.7m | €0.5m | €0.4m | ▼ 23.6% |
| Current portion of amounts payable after more than one year42 | €0.09m | €0.1m | €0.1m | €0.1m | €0.04m | ▼ 67.2% |
| Financial debts43 | €0.02m | €0.02m | €0.02m | €0.03m | €0.03m | ▼ 0.5% |
| Other loans439 | €0.02m | €0.02m | €0.02m | €0.03m | €0.03m | ▼ 0.5% |
| Trade debts44 | €0.001m | €0.001m | €0.001m | €0.002m | €0.004m | ▲ 105% |
| Suppliers440/4 | €0.001m | €0.001m | €0.001m | €0.002m | €0.004m | ▲ 105% |
| Taxes, remuneration and social security45 | €0.001m | €0.008m | €0.02m | €0.02m | €0.02m | ▲ 6.7% |
| Taxes450/3 | €0.001m | €0.008m | €0.02m | €0.02m | €0.02m | ▲ 6.7% |
| Other amounts payable47/48 | €0.6m | €0.7m | €0.5m | €0.3m | €0.3m | ▼ 11.5% |
| Accrued charges and deferred income492/3 | - | - | - | €0.007m | €0.003m | ▼ 50.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €127,058 | €156,539 | €134,683 | €149,006 | €157,945 | ▲ 6.0% |
| + Depreciation and write-downs630 | - | - | - | - | €1,737 | - |
| Operating cash flow (approximation) | €127,058 | €156,539 | €134,683 | €149,006 | €159,682 | ▲ 7.2% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | -€18,480 | - |
| Change in cash | - | €48,462 | €165,758 | -€184,578 | -€68,421 | ▲ 62.9% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Comparable companies
Similar companies · same sector, comparable size
MAGELINA
BE 0421.299.902
Scherpenheuvel-Zichem · Eq €1,255,608
D.W. INVEST
BE 0869.724.269
Heist-op-den-Berg · Eq €1,255,371
MOERMAN DMC
BE 0738.583.140
Kruisem · Eq €1,255,292
Holding Van Roo
BE 0564.802.690
Bonheiden · Eq €1,255,989
B.D. ENGINEERING
BE 0467.139.132
Tielt · Eq €1,256,015
Of 24,727 companies in this sector we hold annual accounts for 19,807. 12,182 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Board & ownership
1 holding
Directors
Directors
No directors read yet: 0 of 3 Gazette acts processed. See the function holders in the CBE →
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 1
-
100%
According to the 2025 annual accounts of PHARMASENSE and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No directors read yet: 0 of 3 Gazette acts processed.
Timeline
12 eventsLatest 28-08-2026Next filing 31-07-2027
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
2025
31-12
Financial
Highest result since 2018net €157,945 ▲6%
Operating result €240,835, net result €157,945, both a record.
26-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 26 days late
2024
21-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 21 days late
2023
31-12
Financial
Equity above €1mEq €1.1m ▲13.7%
6 profitable years in a row build equity to €1.1m.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
22-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
15-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
16-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
2017
19-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Company details
Private limited company · founded 25-06-2010Year ends 31-12Peppol reachable1 site
Register details
Identification
Legal formPrivate limited company
Founded25-06-2010
Fiscal year end31-12
Activities, NACEBEL 2025
64210Activities of holding companies
70200Business and other management consultancy
E-invoicing
Reachable via Peppol
Peppol ID
0208:0827039024
Also
9925:BE0827039024
Registered
29-04-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Location & real-estate footprint
Registered office, Heist-op-den-Berg · 1 establishment unit since 2010
Ground area
1,165 m²
Building footprint
262 m²
Volume, LiDAR
1,504 m³
Parcel 12017C0153/00D002, Flanders · tallest building 10.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
PHARMASENSE
since 2010unit no. 2.189.512.803
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12017C0153/00D002 | Flanders | 1,165 m² | 1 · 262 m² | 10.8 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What changed in the latest annual accounts?What changed What held for this company on a given day: board, seat, name?Company as of a date
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.